Zimmer Biomet Holdings (ZBH) Other Non Operating Income (2014 - 2026)
Zimmer Biomet Holdings' (ZBH) quarterly Other Non Operating Income came in at -$3.0 million in Q1 2026, down 203.45% year-on-year from $2.9 million in Q1 2025, and up 54.55% quarter-over-quarter from -$6.6 million in Q4 2025.
Zimmer Biomet Holdings (ZBH) Other Non Operating Income (2014 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Other Non Operating Income history runs 13 years deep, the most recent figure standing at -$3.0 million for Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 203.45% year-over-year to -$3.0 million in Q1 2026; TTM through Mar 2026 was -$2.4 million, a 91.46% increase from a year earlier, with the FY2025 full-year figure at $3.5 million, up 111.25% from the prior year.
- Other Non Operating Income grew to -$3.0 million in Q1 2026 per ZBH's latest filing, from -$6.6 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $7.7 million in Q1 2023 and bottomed at -$56.1 million in Q1 2022.
- The 5-year median for Other Non Operating Income is -$1.2 million (2023), against an average of -$9.9 million.
- Across the five-year window, Other Non Operating Income plunged 8566.67% in 2022 and jumped 3000.0% in 2025, its largest moves.
- Year by year, Other Non Operating Income stood at -$3.9 million in 2022, then sank by 402.56% to -$19.6 million in 2023, then plunged by 94.39% to -$38.1 million in 2024, then soared by 82.68% to -$6.6 million in 2025, then soared by 54.55% to -$3.0 million in 2026.
- Per Business Quant, the three latest ZBH Other Non Operating Income figures stand at -$3.0 million (Q1 2026), -$6.6 million (Q4 2025), and $3.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Zimmer Biomet Holdings | 17.48 Bn | 17.07 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.00 Mn |
| Dec 31, 2025 | -6.60 Mn |
| Sep 30, 2025 | 3.30 Mn |
| Jun 30, 2025 | 3.90 Mn |
| Mar 31, 2025 | 2.90 Mn |
| Dec 31, 2024 | -38.10 Mn |
| Sep 30, 2024 | 5.10 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Mar 31, 2024 | -100,000.00 |
| Dec 31, 2023 | -19.60 Mn |
| Sep 30, 2023 | 3.80 Mn |
| Jun 30, 2023 | -1.20 Mn |
| Mar 31, 2023 | 7.70 Mn |
| Dec 31, 2022 | -3.90 Mn |
| Sep 30, 2022 | -25.40 Mn |
| Jun 30, 2022 | -42.60 Mn |
| Mar 31, 2022 | -56.10 Mn |
| Dec 31, 2021 | -3.80 Mn |
| Sep 30, 2021 | 300,000.00 |
| Jun 30, 2021 | 8.00 Mn |